Patents by Inventor David J. FONTANA

David J. FONTANA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination of Anti-LAG-3 Antibodies and Anti-PD-1 Antibodies to Treat Tumors
    Publication number: 20220185892
    Abstract: Provided are methods for clinical treatment of tumors (e.g., advanced solid tumors) using an anti-LAG-3 antibody in combination with an anti-PD-1 antibody.
    Type: Application
    Filed: February 28, 2022
    Publication date: June 16, 2022
    Inventors: Alan J. KORMAN, Nils LONBERG, David J. FONTANA, Andres A. GUTIERREZ, Mark J. SELBY, Katherine LEWIS
  • Combination of anti-LAG-3 antibodies and anti-PD-1 antibodies to treat tumors
    Patent number: 11274152
    Abstract: Provided are methods for clinical treatment of tumors (e.g., advanced solid tumors) using an anti-LAG-3 antibody in combination with an anti-PD-1 antibody.
    Type: Grant
    Filed: September 11, 2020
    Date of Patent: March 15, 2022
    Assignee: Bristol-Myers Squibb Company
    Inventors: Alan J. Korman, Nils Lonberg, David J. Fontana, Andres A. Gutierrez, Mark J. Selby, Katherine Lewis
  • Combination of Anti-LAG-3 Antibodies and Anti-PD-1 Antibodies to Treat Tumors
    Publication number: 20210009692
    Abstract: Provided are methods for clinical treatment of tumors (e.g., advanced solid tumors) using an anti-LAG-3 antibody in combination with an anti-PD-1 antibody.
    Type: Application
    Filed: September 11, 2020
    Publication date: January 14, 2021
    Inventors: Alan J. KORMAN, Nils LONBERG, David J. FONTANA, Andres A. GUTIERREZ, Mark J. SELBY, Katherine LEWIS
  • COMBINATION OF ANTI-LAG-3 ANTIBODIES AND ANTI-PD-1 ANTIBODIES TO TREAT TUMORS
    Publication number: 20200062845
    Abstract: Provided are methods for clinical treatment of tumors (e.g., advanced solid tumors) using an anti-LAG-3 antibody in combination with an anti-PD-1 antibody.
    Type: Application
    Filed: April 5, 2019
    Publication date: February 27, 2020
    Applicant: Bristol-Myers Squibb Company
    Inventors: Alan J. Korman, Nils Lonberg, David J. Fontana, Andres A. Gutierrez, Mark J. Selby, Katherine Lewis
  • Combination of anti-LAG-3 antibodies and anti-PD-1 antibodies to treat tumors
    Patent number: 10081681
    Abstract: Provided are methods for clinical treatment of tumors (e.g., advanced solid tumors) using an anti-LAG-3 antibody in combination with an anti-PD-1 antibody.
    Type: Grant
    Filed: September 18, 2014
    Date of Patent: September 25, 2018
    Assignee: Bristol-Myers Squibb Company
    Inventors: Alan J. Korman, Nils Lonberg, David J. Fontana, Andres A. Gutierrez, Mark J. Selby, Katherine E. Lewis
  • COMBINATION OF ANTI-LAG-3 ANTIBODIES AND ANTI-PD-1 ANTIBODIES TO TREAT TUMORS
    Publication number: 20160222116
    Abstract: Provided are methods for clinical treatment of tumors (e.g., advanced solid tumors) using an anti-LAG-3 antibody in combination with an anti-PD-1 antibody.
    Type: Application
    Filed: September 18, 2014
    Publication date: August 4, 2016
    Inventors: Alan J. KORMAN, Nils LONBERG, David J. FONTANA, Andres A. GUTIERREZ, Mark J. SELBY, Katherine E. LEWIS